Advertisement

Gastro-News

, Volume 6, Issue 3, pp 35–40 | Cite as

Lymphoplasmazelluläre Entzündung, obliterative Phlebitis, Organfibrose

IgG4-assoziierte Erkrankungen des Gastrointestinaltrakts

  • Constanze H. WaggershauserEmail author
  • Martin Storr
fortbildung
  • 22 Downloads

IgG4-assoziierte Erkrankungen sind Systemerkrankungen mit verschiedenen Manifestationen, die eine spezifische Pathologie, Serologie und klinische Symptomatik teilen. Verschiedene Verlaufsformen können gleichzeitig oder nacheinander auftreten. Für Gastroenterologen sind vor allem AIP Typ 1, die sklerosierende Cholangitis, die retroperitoneale Fibrose, die Aortitis und Periaortitis, die tubulointestinael Nepritis und eine Lymphadenopathie von Bedeutung.

Literatur

  1. 1.
    Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460–71. Epub 2014/12/08.CrossRefGoogle Scholar
  2. 2.
    Stone JH, Zen Y, Deshpande V. IgG4-related disease. The New England journal of medicine. 2012;366(6):539–51. Epub 2012/02/10.CrossRefGoogle Scholar
  3. 3.
    Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2012;25(9):1181–92. Epub 2012/05/19.CrossRefGoogle Scholar
  4. 4.
    Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Annals of the rheumatic diseases. 2015;74(1):14–8. Epub 2014/03/22.CrossRefGoogle Scholar
  5. 5.
    Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51(1):1–4. Epub 2002/06/22.CrossRefGoogle Scholar
  6. 6.
    Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. The American journal of surgical pathology. 2010;34(12):1812–9. Epub 2010/11/26.CrossRefGoogle Scholar
  7. 7.
    Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466–75. Epub 2015/05/20.CrossRefGoogle Scholar
  8. 8.
    Fragoulis GE, Moutsopoulos HM. IgG4 syndrome: old disease, new perspective. The Journal of rheumatology. 2010;37(7):1369–70. Epub 2010/07/03.CrossRefGoogle Scholar
  9. 9.
    Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annual review of pathology. 2014;9:315–47. Epub 2013/10/12.CrossRefGoogle Scholar
  10. 10.
    Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. The American journal of surgical pathology. 2006;30(12):1537–45. Epub 2006/11/24.CrossRefGoogle Scholar
  11. 11.
    Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45(6):1538–46. Epub 2007/05/24.CrossRefGoogle Scholar
  12. 12.
    Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. The Journal of allergy and clinical immunology. 2016;138(3):825–38. Epub 2016/03/15.CrossRefGoogle Scholar
  13. 13.
    Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. Journal of gastroenterology. 2011;46(3):277–88. Epub 2011/04/01.CrossRefGoogle Scholar
  14. 14.
    Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139(1):140–8; quiz e12-3. Epub 2010/04/01.CrossRefGoogle Scholar
  15. 15.
    Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. Journal of gastroenterology. 2006;41(12):1197–205. Epub 2007/02/09.CrossRefGoogle Scholar
  16. 16.
    Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. Journal of gastroenterology. 2007;42 Suppl 18:6–8. Epub 2007/05/24.CrossRefGoogle Scholar
  17. 17.
    Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? The American journal of digestive diseases. 1961;6:688–98. Epub 1961/07/01.CrossRefGoogle Scholar
  18. 18.
    Tang CSW, Sivarasan N, Griffin N. Abdominal manifestations of IgG4-related disease: a pictorial review. Insights into imaging. 2018;9(4):437–48. Epub 2018/04/27.CrossRefGoogle Scholar
  19. 19.
    Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Current opinion in rheumatology. 2011;23(1):57–66. Epub 2010/12/03.CrossRefGoogle Scholar
  20. 20.
    Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Current opinion in rheumatology. 2011;23(1):88–94. Epub 2010/11/03.CrossRefGoogle Scholar
  21. 21.
    Ozawa M, Fujinaga Y, Asano J, Nakamura A, Watanabe T, Ito T, et al. Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis research & therapy. 2017;19(1):223. Epub 2017/10/06.CrossRefGoogle Scholar
  22. 22.
    Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney international. 2010;78(10):1016–23. Epub 2010/08/20.CrossRefGoogle Scholar
  23. 23.
    Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, et al. Chronic gastritis in the setting of autoimmune pancreatitis. The American journal of surgical pathology. 2010;34(9):1241–9. Epub 2010/08/11.CrossRefGoogle Scholar
  24. 24.
    Wong DD, Pillai SR, Kumarasinghe MP, McGettigan B, Thin LW, Segarajasingam DS, et al. IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer. The American journal of surgical pathology. 2012;36(6):929–34. Epub 2012/03/01.CrossRefGoogle Scholar
  25. 25.
    Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31(1):28–31. Epub 2005/06/22.CrossRefGoogle Scholar
  26. 26.
    Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67(7):1688–99. Epub 2015/03/27.CrossRefGoogle Scholar
  27. 27.
    Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. Journal of gastroenterology. 2010;45(5):471–7. Epub 2010/03/10.CrossRefGoogle Scholar
  28. 28.
    Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134(3):706–15. Epub 2008/01/29.CrossRefGoogle Scholar
  29. 29.
    Yunyun F, Yu C, Panpan Z, Hua C, Di W, Lidan Z, et al. Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Scientific reports. 2017;7(1):6195. Epub 2017/07/25.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Internistisches Klinikum München SüdMünchenDeutschland
  2. 2.Zentrum für Endoskopie, StarnbergStarnbergDeutschland

Personalised recommendations